Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Trypanosoma brucei | myosin heavy chain kinase A, putative | 0.00423136 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Leishmania major | myosin heavy chain kinase a-like protein | 0.00423136 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Trypanosoma brucei | myosin heavy chain kinase A, putative | 0.00423136 | 1 | 0.5 |
Echinococcus granulosus | eukaryotic elongation factor 2 kinase | 0.00423136 | 1 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.00126667 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Schistosoma mansoni | eukaryotic elongation factor 2 kinase (eef-2 kinase) | 0.00423136 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00423136 | 1 | 0.5 |
Brugia malayi | MHCK/EF2 kinase domain family protein | 0.00423136 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.00126667 | 0 | 0.5 |
Trypanosoma cruzi | myosin heavy chain kinase A, putative | 0.00423136 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.00126667 | 0 | 0.5 |
Trypanosoma cruzi | myosin heavy chain kinase A, putative | 0.00423136 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.00126667 | 0 | 0.5 |
Echinococcus multilocularis | eukaryotic elongation factor 2 kinase | 0.00423136 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.00126667 | 0 | 0.5 |
Entamoeba histolytica | elongation factor-2 kinase, putative | 0.00126667 | 0 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.00126667 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | Antiparasitic activity against amastigote stage of Trypanosoma cruzi Y | ChEMBL. | 26821820 | |
IC50 (functional) | = 4.5 uM | Antiparasitic activity against trypomastigote stage of Trypanosoma cruzi Y assessed as parasite viability after 24 hrs by MTT assay | ChEMBL. | 26821820 |
IC50 (functional) | = 123.4 uM | Antiparasitic activity against promastigote stage of Leishmania infantum assessed as parasite viability after 24 hrs by MTT assay | ChEMBL. | 26821820 |
MIC (functional) | = ug ml-1 | Minimum fungicidal concentration of the compound against Saccharomyces cerevisiae(no antifungal activity) | ChEMBL. | 11212107 |
MIC (functional) | = 0 ug ml-1 | Minimum fungicidal concentration of the compound against Saccharomyces cerevisiae(no antifungal activity) | ChEMBL. | 11212107 |
Potency (functional) | 21.8028 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 24.5442 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the AP-1 signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 48.8105 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the AP-1 signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 48.9722 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the NFkB signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 54.7663 uM | PubChem BioAssay: Tox21. qHTS assay for small molecule activators of the heat shock response signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 54.7663 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 54.7663 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the NFkB signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 54.9477 uM | PubChem BioAssay: Tox21. qHTS assay for small molecule activators of the heat shock response signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 54.9477 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 60.9441 uM | PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Ratio IC50 (functional) | = 16 | Potency index, ratio of benznidazole IC50 to compound IC50 for trypomastigote stage of Trypanosoma cruzi Y | ChEMBL. | 26821820 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma cruzi | ChEMBL23 | 26821820 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.